Evidence map›Paper›PMID 22959881›Full record

Trial reportAmerican journal of ophthalmology2012

Nocardia keratitis: clinical course and effect of corticosteroids.

Prajna Lalitha, Muthiah Srinivasan, Revathi Rajaraman, Meenakshi Ravindran, Jeena Mascarenhas, Jeganathan Lakshmi Priya, Aileen Sy, Catherine E Oldenburg, Kathryn J Ray, Michael E Zegans and 3 more

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of ophthalmology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Nocardiosis: A Neglected Disease.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2020
    Pooled it
  3. Topical corticosteroids as adjunctive therapy for bacterial keratitis.The Cochrane database of systematic reviews · 2014
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Diagnosis and management of paediatricOxford medical case reports · 2026
    Article
  9. Article
  10. Advances in the molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2026
    Review
  11. Nocardia infection following ocular surface surgery.International ophthalmology · 2023
    Article
  12. Article
  13. Review
  14. Current diagnostic tools and management modalities of Nocardia keratitis.Journal of ophthalmic inflammation and infection · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Role of steroids in the treatment of bacterial keratitis.Clinical ophthalmology (Auckland, N.Z.) · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Prajna LalithaAravind Eye Care System, Madurai, India.
Muthiah Srinivasan
Revathi Rajaraman
Meenakshi Ravindran
Jeena Mascarenhas
Jeganathan Lakshmi Priya
Aileen Sy
Catherine E Oldenburg
Kathryn J Ray
Michael E Zegans
Stephen D McLeod
Thomas M Lietman
Nisha R Acharya
Aravind Eye Hospital · INSan Francisco Foundation · USUniversity of California, San Francisco · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
The Steroids for Cornea Ulcers TrialU10EY015114 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2005 to 2009
$2.4M
Predicting and Improving Clinical Outcomes for Bacterial KeratitisK23EY017897 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACHARYA, NISHA · 2007 to 2011
$1.1M
NEI NIH HHS EY02162NEI NIH HHS K23 EY017897NEI NIH HHS K23EY017897NEI NIH HHS P30 EY002162NEI NIH HHS U10 EY015114
6 · The paper itself

Abstract

purposeTo compare the clinical course of Nocardia species keratitis with keratitis resulting from other bacterial organisms and to assess the effect of corticosteroids as adjunctive therapy using data collected from the Steroids for Corneal Ulcers Trial.

designSubgroup analysis of a randomized controlled trial.

methodssetting: Multicenter randomized controlled trial. study population: Five hundred patients with bacterial keratitis randomized 1:1 to topical corticosteroid or placebo who had received at least 48 hours of topical moxifloxacin. intervention/observation procedure: Topical prednisolone phosphate 1% or placebo and clinical course of Nocardia keratitis. main outcome measures: Best spectacle-corrected visual acuity and infiltrate or scar size at 3 months from enrollment.

resultsOf 500 patients enrolled in the trial, 55 (11%) had a Nocardia corneal ulcer. Patients with Nocardia ulcers had better presentation visual acuity compared with non-Nocardia ulcers (median Snellen visual acuity, 20/45, compared with 20/145; P < .001) and comparable 3-month visual acuity (median, 20/25, vs 20/40; P = .25). Nocardia ulcers had approximately 2 lines less of improvement in visual acuity compared with non-Nocardia ulcers (0.21 logarithm of the minimal angle of resolution; 95% confidence interval, 0.09 to 0.33 logarithm of the minimal angle of resolution; P = .001). This difference may reflect the better starting visual acuity in patients with Nocardia ulcers. In Nocardia ulcers, corticosteroids were associated with an average 0.4-mm increase in 3-month infiltrate or scar size (95% confidence interval, 0.03 to 0.77 mm; P = .03).

conclusionsNocardia ulcers responded well to treatment. They showed less overall improvement in visual acuity than non-Nocardia ulcers, but had better presentation acuity. Corticosteroids may be associated with worse outcomes.

Indexed as

Administration, TopicalAdultAnti-Infective AgentsAza CompoundsCorneal UlcerDouble-Blind MethodEye Infections, BacterialFemaleFluoroquinolonesGlucocorticoidsHumansMaleMiddle AgedMoxifloxacinNocardiaNocardia InfectionsAnti-Infective AgentsAza CompoundsFluoroquinolonesGlucocorticoidsMoxifloxacinPrednisoloneprednisolone phosphateQuinolines

Identifiers

PMID22959881
PMCPMC3498612
OpenAlexW1997197495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.